MUFG Americas Holdings Corp increased its holdings in shares of CME Group Inc (NASDAQ:CME) by 6.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 18,655 shares of the financial services provider’s stock after purchasing an additional 1,197 shares during the period. MUFG Americas Holdings Corp’s holdings in CME Group were worth $2,725,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Capital International Investors boosted its stake in CME Group by 11.4% in the third quarter. Capital International Investors now owns 12,489,045 shares of the financial services provider’s stock valued at $1,694,514,000 after acquiring an additional 1,279,058 shares in the last quarter. Atlantic Trust Group LLC boosted its stake in CME Group by 1,943.2% in the third quarter. Atlantic Trust Group LLC now owns 606,942 shares of the financial services provider’s stock valued at $82,349,000 after acquiring an additional 577,237 shares in the last quarter. Westfield Capital Management Co. LP boosted its stake in CME Group by 526.4% in the third quarter. Westfield Capital Management Co. LP now owns 565,472 shares of the financial services provider’s stock valued at $76,723,000 after acquiring an additional 475,192 shares in the last quarter. Jackson Square Partners LLC acquired a new stake in CME Group in the third quarter valued at approximately $48,724,000. Finally, Canada Pension Plan Investment Board boosted its stake in CME Group by 54.0% in the third quarter. Canada Pension Plan Investment Board now owns 872,837 shares of the financial services provider’s stock valued at $118,427,000 after acquiring an additional 305,900 shares in the last quarter. Hedge funds and other institutional investors own 82.85% of the company’s stock.
Shares of CME Group Inc (CME) opened at $162.38 on Friday. CME Group Inc has a one year low of $114.82 and a one year high of $165.35. The company has a current ratio of 1.03, a quick ratio of 1.05 and a debt-to-equity ratio of 0.10. The company has a market cap of $55,991.28, a price-to-earnings ratio of 13.60, a PEG ratio of 2.14 and a beta of 0.64.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 26th. Stockholders of record on Friday, March 9th will be paid a dividend of $0.70 per share. This is an increase from CME Group’s previous quarterly dividend of $0.66. This represents a $2.80 annualized dividend and a dividend yield of 1.72%. The ex-dividend date of this dividend is Thursday, March 8th. CME Group’s payout ratio is presently 22.11%.
In related news, COO Julie Holzrichter sold 12,920 shares of the firm’s stock in a transaction on Tuesday, November 28th. The shares were sold at an average price of $144.08, for a total transaction of $1,861,513.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Chairman Terrence A. Duffy sold 20,000 shares of the firm’s stock in a transaction on Tuesday, February 6th. The stock was sold at an average price of $151.66, for a total transaction of $3,033,200.00. Following the transaction, the chairman now directly owns 99,239 shares of the company’s stock, valued at approximately $15,050,586.74. The disclosure for this sale can be found here. Insiders have sold 64,728 shares of company stock valued at $9,755,257 over the last quarter. Insiders own 0.57% of the company’s stock.
CME has been the subject of several recent analyst reports. BidaskClub downgraded shares of CME Group from a “buy” rating to a “hold” rating in a research note on Tuesday, December 19th. Zacks Investment Research upgraded shares of CME Group from a “hold” rating to a “buy” rating and set a $164.00 target price for the company in a research note on Tuesday, January 2nd. Goldman Sachs Group upgraded shares of CME Group from a “neutral” rating to a “buy” rating and set a $180.00 target price for the company in a research note on Wednesday, February 7th. Citigroup restated a “buy” rating and issued a $172.00 target price (up from $155.00) on shares of CME Group in a research note on Monday, January 29th. Finally, Berenberg Bank initiated coverage on shares of CME Group in a research note on Thursday, January 25th. They issued a “hold” rating and a $170.00 target price for the company. Three research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company. CME Group has an average rating of “Buy” and an average target price of $157.00.
COPYRIGHT VIOLATION WARNING: This story was first reported by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this story on another publication, it was stolen and reposted in violation of US & international copyright and trademark legislation. The legal version of this story can be read at https://stocknewstimes.com/2018/02/17/mufg-americas-holdings-corp-acquires-1197-shares-of-cme-group-inc-cme.html.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.